A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
Neither clinical trials nor an application for federal approval from the Food and Drug Administration (FDA) are underway, meaning it's highly unlikely the state-manufactured insulin will be ...
Inc., the nonprofit drug manufacturer contracted to produce insulin for California, has not started clinical trials or applied for approval from the federal Food and Drug Administration, both of which ...
The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...
Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...
The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug ...
An executive order signed by former President Joe Biden aimed at lowering prescription drug prices was among those voided by President Donald Trump's flurry of executive orders this week.
On the first day of his second term, President Donald Trump signed an executive order revoking dozens of the Biden administration ... model capping insulin costs at $35 per month for people on ...